The Latest Cardiac and Vascular News
MINNEAPOLIS–(BUSINESS WIRE)– Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor’s Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in […]
Multicenter Study to Evaluate Balloon Ablation Catheter for Safety and Effectiveness in Achieving Pulmonary Vein Isolation in Treatment of Paroxysmal Atrial Fibrillation IRVINE, CA, MARCH 15 – Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a […]
IRVINE, CA, — March 13, 2018 — Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has completed patient enrollment in its U.S. Investigational Device Exemption […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the Transcatheter Cardiovasular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Denver, CO October 29 – November 2, […]
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow Inc., a medical device company based in Anaheim, California, has announced the publication of significantly positive results in a study evaluating the company’s PleuraFlow® Active Clearance Technology® System. Data from a peer-reviewed clinical study indicating a marked reduction in Postoperative […]
RE-DUAL PCI™ showed large reductions in the incidence of bleeding complications if Pradaxa® dual therapy was used instead of warfarin triple therapy. Both Pradaxa® doses tested in RE-DUAL PCI™ have been approved for stroke prevention in atrial fibrillation. Data were presented as […]
VANCOUVER, Aug. 21, 2017 /PRNewswire/ – Cardiome Pharma Corp. (NASDAQ: CRME/ TSX:COM) today announced that it has received a response from the U.S. Food and Drug Administration (FDA) regarding the regulatory path for BRINAVESS® (vernakalant hydrochloride, IV), the Company’s antiarrhythmic drug for the […]
MARLBOROUGH, Mass., July 31, 2017 /PRNewswire/ — CardioFocus, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF) in Japan. The HeartLight System is a visually guided laser […]
MARLBOROUGH, Mass., June 29, 2017/PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical studies […]
AUSTIN, Texas, March 21, 2017 /PRNewswire/ — On March 1, 2017, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center was the first in Texas and among the first facilities in the U.S. to use the FlexAbility™ Ablation […]
